Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
David LinetskyPoint-of-Care Marketing
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
YONKERS, N.Y., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...
Allogene to Initiate the ALPHA Study for ALLO-501 in Relapsed/Refractory Non-Hodgkin LymphomaALLO-647, Allogene’s Proprietary ...
- Focusing Resources on Uveitis Program; NDA Filing Expected Fourth Quarter 2018 - - ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email